Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

Officials cited data showing the new Alzheimer ’s drug has serious safety risks and may not help patients.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Clinical Trials Aduhelm (Drug) Medicare Alzheimer ' s Disease Health Insurance and Managed Care s Assn Biogen Inc Centers for Medicare and Medicaid Services Food and Drug Administration Source Type: news